ライフサイエンスコーパス: paracentesis

1 inistered at the time of large-volume (>5 L) paracentesis.

2 Complications occurred in 5.7% of AC paracentesis.

3 al load at time of positive anterior chamber paracentesis.

4 1.3% female, mean age 56.7 years) and 528 AC paracentesis.

5 ated the safety and diagnostic utility of AC paracentesis.

6 ferior vena cava filter, gastric bypass, and paracentesis.

7 cedural hemorrhage among patients undergoing paracentesis.

8 nly 1 patient (SOC group) after large-volume paracentesis.

9 anterior chamber (AC) via peripheral corneal paracentesis.

10 ents undergoing therapeutic anterior chamber paracentesis.

11 vatively and 59 patients received additional paracentesis.

12 on systemic hemodynamics at patients' first paracentesis.

13 04), and 6 hours (+6 mmHg); p = 0.050) after paracentesis.

14 between first symptoms and implementation of paracentesis.

15 chylous effusions normally requires invasive paracentesis.

16 er current standard therapy with and without paracentesis.

17 r refractory ascites frequently necessitates paracentesis.

18 ), and 6 hours (6; IQR 4-6; p = 0.012) after paracentesis.

19 5/m2; p = 0.016) when measured 2 hours after paracentesis.

20 een first symptoms and the implementation of paracentesis.

21 because of PCR results from anterior chamber paracentesis.

22 and improves outcome following large volume paracentesis.

23 line and at key time points during and after paracentesis.

24 and (3) the resources used for large-volume paracentesis.

25 opriate when experienced personnel carry out paracentesis.

26 19.85, p =0.01), with 1.75 fewer episodes of paracentesis (0.925-2.59, p <0.001) on CTI.

27 osis who underwent therapeutic thoracentesis/paracentesis, 177 met criteria for RH and 422 for RA.

28 ys was observed in 26.7% of patients without paracentesis, 36.4% of patients with paracentesis within

29 ypropylene), and vitreous strand at inferior paracentesis (5.3%).

30 ntrolled, compared to patients with need for paracentesis 6 weeks after TIPS (median survival: 185 vs

31 50 patients with sterile ascites on initial paracentesis, 7 patients developed peritonitis during fo

32 Anterior chamber paracentesis (ACP) was performed in both eyes of six New

33 ted in charts, were common for patients with paracentesis after diagnosis with ascites, patients that

34 alopathy, and long-term (>3 months) need for paracentesis after TIPS placement were evaluated and cal

35 rvey study to assess practice patterns on AC paracentesis and a retrospective diagnostic and safety s

36 al load at time of positive anterior chamber paracentesis and association between topical corticoster

37 atedly administered topically 3 hours before paracentesis and continued for 90 minutes afterward.

38 ined as survival with no further therapeutic paracentesis and decreased ascites.

39 s permissible for diagnostic and therapeutic paracentesis and diagnostic endoscopy.

40 eed their benefits for outpatient diagnostic paracentesis and diagnostic endosopies.

41 or chamber (AC) through a clear corneal 1 mm paracentesis and directed at the trabecular meshwork adj

42 Paracentesis and fluid analysis was performed in these p

43 ey injury (AKI) and death after large-volume paracentesis and in patients with spontaneous bacterial

44 he patient was treated with anterior chamber paracentesis and intraocular pressure lowering drops.

45 management change based on anterior chamber paracentesis and PCR.

46 the absence of any tangible effectiveness of paracentesis and the inherent risks of paracentesis such

47 iple contexts relating to the performance of paracentesis and upper endoscopy.

48 drothorax should be managed with therapeutic paracentesis and/or thoracentesis, respectively, with th

49 had a complete response (required no further paracentesis) and 11 patients (22%) had a partial respon

50 ast year of life (not involving large-volume paracentesis), and number of large-volume paracentesis p

51 een proposed, including cataract extraction, paracentesis, and argon laser iridoplasty.

52 omes were alteration of treatment, safety of paracentesis, and correlation of keratitic precipitates

53 ent; infectious workup, including diagnostic paracentesis, and evaluation of secondary causes (thyroi

54 es foci of sepsis, for appropriate sites for paracentesis, and to assess for vascular disorders such

55 herapy to ascites [repeated thoracentesis or paracentesis, and transjugular intrahepatic portosystemi

56 reated with ocular massage, anterior chamber paracentesis, and/or hemodilution (conservative treatmen

57 r placement; lumbar puncture; thoracentesis; paracentesis; and intubation/mechanical ventilation) was

58 or encephalopathy should receive diagnostic paracentesis as soon as possible.

59 r (50 mul) were obtained by anterior chamber paracentesis as the first step of routine cataract surge

60 s not required for diagnostic or therapeutic paracentesis as well as diagnostic endoscopy.

61 s with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments in

62 standard in-patient therapy with and without paracentesis at the Dr.

63 patients with cirrhosis who had their first paracentesis at the Medical University of Vienna from 20

64 ients who underwent at least 1 outpatient AC paracentesis at UCSF from 2012 to 2023 were included in

65 n infusion is recommended after large-volume paracentesis, at diagnosis of spontaneous bacterial peri

66 atients with (BCVA 1.9 +/- 0.31) and without paracentesis (BCVA 1.75 +/- 0.32) (p = 0.9), nor among t

67 utpatients with cirrhotic ascites undergoing paracentesis between July 1994 and December 2000.

68 In conclusion, large-volume paracentesis can be performed safely as an outpatient pr

69 d in conjunction with occurence rate of post-paracentesis clinically significant hemorrhage, defined

70 2 L of drainage and 94.3 pg/mL at the end of paracentesis, compared with an increase of 10.5 pg/mL an

71 Four patients encountered paracentesis complications (4/53, 7.5%), 1 with long-ter

72 s were to determine (1) whether large-volume paracentesis could be performed safely and effectively b

73 on of gallbladder stones in the pelvis while paracentesis documented hemoperitoneum.

74 is such as intraocular infection and injury, paracentesis does not appear to be warranted as a treatm

75 Among paracentesis events for patients with a diagnosis of cir

76 % for assays for cell number and type in the paracentesis fluid.

77 s ascites should be treated with therapeutic paracentesis followed by colloid volume expansion, and d

78 ponse (required less frequent but additional paracentesis for control of ascites).

79 with cirrhosis, patients undergoing lateral paracentesis had a mean MELD 3.0 score of 22 ( sd , 8.46

80 and were more likely to require therapeutic paracentesis (HR 2.26; p = 0.02) in the next 90 days.

81 peritonitis (HR, 0.55 [95% CI, 0.46-0.65]), paracentesis (HR, 0.54 [95% CI, 0.50-0.60]), variceal bl

82 uencing and specific PCR on anterior chamber paracentesis identified JC polyomavirus DNA.

83 A 10-L paracentesis improved abdominal discomfort and disclosed

84 and respiratory parameters before and after paracentesis in 50 critically ill patients with advanced

85 serious complication of large-volume (>5 L) paracentesis in cirrhosis and is reduced with albumin in

86 Paracentesis in critically ill patients is safe regardin

87 sfunction with increased odds of post-90-day paracentesis in outpatient TIPS, hospital admissions for

88 p reduces or abrogates the need for repeated paracentesis in patients with recurrent or refractory as

89 ry outcome was a requirement for therapeutic paracentesis in the 90 days following BNP results.

90 portosystemic shunts (TIPS) vis-a-vis total paracentesis in the management of refractory ascites is

91 een 2013 and 2015, who required large-volume paracentesis in their last year of life.

92 added gain in visual acuity by performing a paracentesis, independent of the time elapsed between fi

93 Paracentesis-induced circulatory dysfunction (PICD) is a

94 Beta-blockade has been associated with paracentesis-induced circulatory dysfunction.

95 perhaps related to beta-blockade associated paracentesis-induced circulatory dysfunction.

96 ous humor liquid biopsy via anterior chamber paracentesis is a safe and well-tolerated procedure in p

97 Anterior chamber (AC) paracentesis is a valuable diagnostic and therapeutic op

98 c agents and hyaluronidase, anterior chamber paracentesis, IV corticosteroid, IV mannitol, and hyperb

99 randomized to TIPS or repeated large volume paracentesis (LVP) for refractory ascites.

100 anges in serum NT-proBNP during large volume paracentesis (LVP) in patients with ascites have never b

101 These data suggest midline paracentesis may reduce the risk of post-procedural hemo

102 ithin 7-24 hours, and 23.1% of patients with paracentesis more than 24 hours after the onset of sympt

103 hether PICD could develop with modest-volume paracentesis (MVP) and the role of albumin infusion.

104 ( sd , 8.46) and patients undergoing midline paracentesis ( n = 118) had a mean MELD 3.0 score of 25

105 py (sodium restriction, diuretics, and total paracentesis) (n = 57) or medical therapy plus TIPS (n =

106 nd detector electrodes on the abdomen during paracentesis of 8-11 L.

107 The potential association of low-volume paracentesis of less than 5 L with complications in pati

108 After paracentesis of the anterior eye chamber, the lacunae be

109 e ascites or requiring frequent large-volume paracentesis on conservative treatment are likely to req

110 our study was to investigate the effects of paracentesis on hemodynamic and respiratory parameters i

111 er disease and tense ascites who performed a paracentesis on himself and developed K. kingae peritoni

112 nd time course of changes observed following paracentesis or diuretic therapy.

113 of uncomplicated ascites, after large-volume paracentesis or in patients with SBP.

114 ascites is managed by repeated large volume paracentesis or insertion of a transjugular intrahepatic

115 neficial in patients undergoing large-volume paracentesis or who have hepatorenal syndrome or spontan

116 hy, ascites requiring sustained diuretics or paracentesis, or coagulopathy unresponsive to vitamin K

117 variceal bleeding, hepatocellular carcinoma, paracentesis, or hemodialysis; and discharge against med

118 oma medications, performing anterior chamber paracentesis, or increasing the interval between injecti

119 - 0.32) (p = 0.9), nor among the groups with paracentesis (p = 0.8).

120 est and could forego the need for diagnostic paracentesis, particularly in cases where the cause of a

121 nostic and safety study of all outpatient AC paracentesis performed between April 2012 and March 2023

122 identify complications from anterior chamber paracentesis performed to obtain AH for liquid biopsy.

123 AO) such as ocular massage, anterior chamber paracentesis, physical exercise, and medication-induced

124 hthalmology residents each performed four AC paracentesis procedures (two with the novel device, two

125 All AC paracentesis procedures achieved >= 100 uL of fluid.

126 tesis ratio (number of day-case large-volume paracentesis procedures as a proportion of the total num

127 rrelated with the proportion of large-volume paracentesis procedures done in a day-case (vs unplanned

128 me paracentesis), and number of large-volume paracentesis procedures in the last year of life.

129 A total of 1203 paracentesis procedures were performed on 484 eyes of 42

130 day-case paracentesis service (care group), paracentesis ratio (number of day-case large-volume para

131 One patient experienced a paracentesis related complication (1/45, 2.2 %) without

132 An ultrasound guided, transvaginal paracentesis removed 4 liters of straw-colored fluid, re

133 e or much more confident about performing AC paracentesis safely with the novel syringe handle than w

134 ife to death, whether enrolled in a day-case paracentesis service (care group), paracentesis ratio (n

135 atients who attended a day-case large-volume paracentesis service within their last year of life had

136 RPRETATION: The use of day-case large-volume paracentesis services in the last year of life was assoc

137 up showed better ascites control, with fewer paracentesis sessions per month (1.57 +/- 0.65 vs. 4.07

138 ent either liver biopsy of mass or abdominal paracentesis, showing gallbladder cancer and adenocarcin

139 mes included incidence of variceal bleeding, paracentesis, spontaneous bacterial peritonitis, hepatic

140 For paracentesis studies, vehicle, BOL-303242-X (0.1%, 0.5%,

141 In the paracentesis study, BOL-303242-X and DEX improved ocular

142 ss of paracentesis and the inherent risks of paracentesis such as intraocular infection and injury, p

143 hage at the procedural site within 7 days of paracentesis that required either blood transfusion, ang

144 vitreal antibiotics with an anterior chamber paracentesis that was not sent for microbiologic samplin

145 Among patients receiving paracentesis, the overall occurence rate of hemorrhage w

146 Large-volume paracentesis, the preferred treatment for patients with

147 and coagulopathy before low-risk therapeutic paracentesis, thoracentesis, and routine upper endoscopy

148 who required more than one anterior chamber paracentesis to detect CMV as the etiologic agent of the

149 Three eyes required paracentesis to reduce the intraocular pressure after in

150 with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostat

151 mong those currently under investigation are paracentesis, ultrafiltration, peritoneal dialysis, oral

152 their first therapeutic thoracentesis/second paracentesis until death or transplantation.

153 ed syringe handle that enables one-handed AC paracentesis using standard 1-mL syringes by allowing si

154 increase in handgrip strength, reduction in paracentesis volume, and improved quality of life in pat

155 utcomes were change in handgrip strength and paracentesis volume.

156 The mean duration of large-volume paracentesis was 97 +/- 24 minutes, and the mean volume

157 The long-term need for paracentesis was greater in the 8-mm group (64 of 111 pa

158 A paracentesis was performed after 48 hours of treatment.

159 Anterior eye chamber paracentesis was performed for polymerase chain reaction

160 The need for large-volume paracentesis was significantly reduced in GDP group, com

161 xperimental chickens subjected to unilateral paracentesis were fixed either by perfusion or in situ,

162 and respiratory parameters before and after paracentesis were performed by Wilcoxon signed-rank test

163 A total of 80 ACLF patients undergoing <5 L paracentesis were randomized to receive albumin (8 g/dL

164 A total of 80 ACLF patients undergoing <5 L paracentesis were randomized to receive albumin (8-10 g/

165 ped a novel syringe handle for one-handed AC paracentesis, which improved the safety and precision of

166 dard of care (SOC; ie, repeated large-volume paracentesis with albumin infusion), and were hospitaliz

167 history, physical evaluation, and abdominal paracentesis with ascitic fluid analysis.

168 Anterior chamber paracentesis with PCR had a relatively low diagnostic ut

169 Anterior chamber paracentesis with PCR of aqueous fluid.

170 erior and posterior uveitis who underwent AC paracentesis with PCR were reviewed.

171 erior uveitis who underwent anterior chamber paracentesis with PCR.

172 cornea and/or uveitis (68%) and performed AC paracentesis with the patient at the slit lamp (75%).

173 ta-analyses on trials comparing large-volume paracentesis with transjugular intrahepatic portosystemi

174 ne patient suffered a lens injury due to the paracentesis, with subsequent need for cataract surgery.

175 iotics within 48 hours, i.v. albumin, repeat paracentesis within 48 hours, recognition of SBP, and pr

176 without paracentesis, 36.4% of patients with paracentesis within 6 hours, 20% of patients with parace

177 entesis within 6 hours, 20% of patients with paracentesis within 7-24 hours, and 23.1% of patients wi

178 died from liver disease and had large-volume paracentesis within their last year of life.